| R-MVST Cells for Treatment of Viral Infections (NCT05183490) | Columbia University | 2022-05-03 |
| Study of Posoleucel (ALVR105,Viralym-M) for Multi-Virus Prevention in Patients Post-Allogeneic Hematopoietic Cell Transplant (NCT05305040) | AlloVir | 2022-03-24 |
| Letermovir Use in Heart Transplant Recipients (NCT04904614) | Tufts Medical Center | 2022-01-05 |
| Adoptive Transfer of pp65-specific T Cells for the Treatment of Refractory Cytomegalovirus (CMV) Infection (NCT02346617) | Yae-Jean Kim | 2022-01-01 |
| Trial to Evaluate the Safety and Immunogenicity of a Modified Vaccinia Ankara (MVA)-Based Anti-Cytomegalovirus (CMV) Vaccine (Triplex®) (NCT05099965) | National Institute of Allergy and Infectious Diseases (NIAID) | 2021-11-02 |
| A Study of Safety and Immune Response to Different Doses of a Cytomegalovirus Vaccine in Healthy Adults (NCT05089630) | GlaxoSmithKline | 2021-10-14 |
| Introduction of mTor Inhibitors and the Activation of the Cytomegalovirus (CMV) -Specific Cellular Immune Response (NCT04936971) | Edoardo Melilli | 2021-09-01 |
| Clinical Performance of SE-SPTM-PCR in Detecting Hcmv-miR-UL22A-5p After Hematopoietic Stem Cell Transplantation (NCT07181330) | Ting YANG | 2021-05-06 |
| Assessment of Post-traumatic Stress Disorder (PTSD) in Patients Monitored for Cytomegalovirus (CMV) Seroconversion During Pregnancy, (NCT04658810) | Hospices Civils de Lyon | 2021-05-02 |
| Inflammation and Co-Infections in D²EFT (NCT04183738) | Kirby Institute | 2021-02-01 |
| Breakthrough CMV Lung Transplant -Multicentre (NCT04439916) | University of Alberta | 2021-01-25 |
| Posoleucel (ALVR105, Formerly Viralym-M) for Multi-Virus Prevention in Patients Post-Allogeneic Hematopoietic Cell Transplant (NCT04693637) | AlloVir | 2021-01-15 |
| Study on Correlation Between Cytomegalovirus and Ocular Myasthenia Gravis (NCT05091177) | XiaoYong Liu | 2021-01-01 |
| ATG Individualized Dosing Model in URD-PBSCT. (NCT06572462) | Chinese PLA General Hospital | 2020-12-31 |
| AntiCMV molécules Monitoring in Real-life in Stem Cell Recipients (NCT04690933) | University Hospital, Limoges | 2020-09-24 |
| Cytomegalovirus (CMV) Viremia and Disease Occurrence in Pediatric Allogeneic Stem Cell Transplantation Recipients (NCT04478474) | New York Medical College | 2020-09-15 |
| Viral Specific T-Lymphocytes to Treat Adenovirus, CMV and EBV (NCT04364178) | Jessie L. Alexander, MD | 2020-08-12 |
| T Cell Therapy of Opportunistic Cytomegalovirus Infection (NCT02982902) | Mari Dallas | 2020-05-27 |
| Empirical Treatment Against Cytomegalovirus and Tuberculosis in HIV-infected Infants With Severe Pneumonia (NCT03915366) | Hospital Universitario 12 de Octubre | 2020-03-01 |
| Treatment of Cytomegalovirus (CMV) Infections With Viral-Specific T Cells (NCT03798301) | University of Wisconsin, Madison | 2020-02-06 |
| Treatment of Low Dose IL-2 and Ganciclovir in Cytomegalovirus Infection (NCT04225780) | Peking University People's Hospital | 2020-02-01 |
| Comparison of Safety and Efficacy of de Novo Everolimus (NCT04906304) | Shahid Beheshti University of Medical Sciences | 2020-01-01 |
| A Dose-Escalation Study Evaluating Safety and Tolerability of Viral-Specific T Cells Against CMV in Adult Solid Organ Transplant Recipients (NCT03950414) | University of Wisconsin, Madison | 2019-09-27 |
| QuantiFERON-CMV Test in a Prediction for Colic Cytomegalovirus Reactivation During Ulcerative Colitis (NCT04030676) | Centre Hospitalier Universitaire de Saint Etienne | 2019-07-17 |
| Anti-CMV Cellular Immunity Quantification Using an IGRA Test in Kidney Transplant récipients and Hemodialysis Patients, Comparison to Control Patients (NCT03916497) | University Hospital, Grenoble | 2019-04-30 |
| Clinical Trial of Efficacy and Safety of the Combination of Reduced Duration Prophylaxis Followed by Immuno-guided Prophylaxis in Lung Transplant Recipients. (NCT03699254) | Maimónides Biomedical Research Institute of Córdoba | 2019-04-05 |
| Safety and Immunogenicity of the Human Cytomegalovirus (CMV) Vaccine (V160) in Healthy Japanese Men (V160-003) (NCT03840174) | Merck Sharp & Dohme LLC | 2019-03-08 |
| Letermovir Treatment for Refractory or Resistant Cytomegalovirus Infection (NCT03728426) | Amy C. Sherman, MD | 2019-01-11 |
| Virus Specific Cytotoxic T-Lymphocytes (CTLs) for Refractory Cytomegalovirus (CMV) (NCT03266640) | New York Medical College | 2018-11-01 |
| Cytomegalovirus Risk in Seropositive Kidney Transplant Recipients Stratified by Quantiferon-CMV (NCT03858907) | University of Sao Paulo General Hospital | 2018-08-05 |
| Antiviral Cellular Therapy for Enhancing T-cell Reconstitution Before or After Hematopoietic Stem Cell Transplantation (NCT03475212) | Pediatric Transplantation & Cellular Therapy Consortium | 2018-06-20 |
| (Val)Ganciclovir TDM in Transplant Recipients (NCT03698435) | University Medical Center Groningen | 2018-05-25 |
| Evaluate Tolerability and Safety of BD03 for Prevention of CMV and BKV Reactivation in Kidney Transplant Recipient (NCT03576014) | SL VAXiGEN | 2018-04-27 |
| Cytomegalovirus (CMV) Reactivation in Allogeneic HSCT Recipient (NCT03806764) | Melbourne Health | 2018-04-17 |
| Pharmacokinetic Parameters of Innovative Valganciclovir Versus Generic Valganciclovir (NCT03631316) | Luis Eduardo Morales Buenrostro | 2018-03-01 |
| Relevance of Gastric Aspirate in HCMV Detection (NCT03262194) | Centre Hospitalier Universitaire de Besancon | 2017-09-19 |
| Development of Potential Biomarkers for Foetal Brain Development After Congenital CMV Infection (NCT03188679) | Universitaire Ziekenhuizen KU Leuven | 2017-07-01 |
| Role of Endothelial Biomarkers in Patients With Coronary Artery Disease (NCT03146208) | Assiut University | 2017-07-01 |
| Non Primary HCMV Infection: Natural History and Immune Response (NCT06337955) | Fondazione IRCCS Policlinico San Matteo di Pavia | 2017-06-06 |
| CMV-CTL for the Treatment of CMV Infection After HSCT (NCT03004261) | Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine | 2016-11-01 |
| Topical 2% Ganciclovir Eye Drop for CMV Anterior Uveitis / Endotheliitis (NCT02943057) | Singapore National Eye Centre | 2016-10-01 |
| Study to Evaluate Safety, Tolerability, and Immunogenicity of Candidate Human Cytomegalovirus Vaccine in Healthy Adults (NCT02826798) | VBI Vaccines Inc. | 2016-06-23 |
| Screening for Congenital Cytomegalovirus Infection in Newborns (NCT02683096) | Southern Illinois University | 2016-02-01 |
| Conversion to Sirolimus: Effects in Cytomegalovirus Infection Recurrence (NCT02671318) | Hospital do Rim e Hipertensão | 2015-09-01 |
| Assessment of CMV-specific ELISPOT Assay for Predicting CMV Colitis in Patient With Ulcerative Colitis (NCT02439372) | Asan Medical Center | 2015-04-01 |
| A Study to Assess Safety and Feasibility of Direct Infusions of Donor-derived Virus-specific T-cells in Recipients of Hematopoietic Stem Cell Transplantation With Post-transplant Viral Infections Using the Cytokine Capture System® (NCT02007356) | University Hospital, Basel, Switzerland | 2014-12-01 |
| Analysis of CMV Infections in Patients With Brain Tumors or Brain Metastases During and After Radio(Chemo)Therapy (NCT02600065) | University of Erlangen-Nürnberg Medical School | 2014-11-01 |
| The Epidemiologic Study of Human Cytomegalovirus（CMV） in Female Students of Xiamen University (NCT02642822) | Jun Zhang | 2014-10-01 |
| ValGanciclovir Versus ValAcyclovir for Viral Prophylaxis in Kidney Transplantation (NCT01972035) | University of Minnesota | 2014-08-01 |
| Immunological Characteristics of Maternal-fetal Transmission of Cytomegalovirus in Pregnancy (NCT02129465) | Shaare Zedek Medical Center | 2014-06-01 |
| The Maternal Cellular Immune System and Cytomegalovirus Intrauterine Infection (NCT01081379) | Shaare Zedek Medical Center | 2014-02-01 |
| Sirolimus Associated With Tacrolimus at Low Doses in Elderly Kidney Transplant Patients (NCT02683291) | Associação Médico Espírita de Botucatu | 2014-01-01 |
| Cytomegalovirus-Specific Response Measured by QuantiFeron® and Overall Immunologic Response Measured by ImmuKnow® in Lung Transplant Patients CMV-positive (NCT02076971) | Fundacio Catalana de Pneumologia | 2014-01-01 |
| Safety, Tolerability, and Immunogenicity of the Human Cytomegalovirus Vaccine (V160) in Healthy Adults (V160-001) (NCT01986010) | Merck Sharp & Dohme LLC | 2013-11-25 |
| Evaluation of Early Use of Everolimus (EVE) on Cytomegalovirus (CMV) Infection in Renal Transplant Recipients (NCT01927588) | Fundação Pró Rim | 2013-08-01 |
| Evaluation of the Pharmacokinetics (PK) and Pharmacodymamics (PD) of Ganciclovir (GCV) in Premature Infants Receiving Treatment for Cytomegalorivus (CMV) Infection (NCT01602614) | University of Alabama at Birmingham | 2013-04-01 |
| Clinical Trial of Behavioral Modification to Prevent Congenital Cytomegalovirus (NCT01819519) | Women and Infants Hospital of Rhode Island | 2013-03-01 |
| A Study of MCMV5322A/MCMV3068A for the Prevention of Cytomegalovirus Disease in High-Risk Kidney Allograft Recipients (NCT01753167) | Genentech, Inc. | 2012-12-14 |
| Everolimus + Very Low Tacrolimus vs Enteric-coated Mycophenolate Sodium + Low Tacrolimus in de Novo Renal Transplant (NCT02084446) | Ronaldo de Matos Esmeraldo, MD | 2012-12-01 |
| The Influence of Chronic CMV Infection on Influenza Vaccine Responses (NCT02134184) | Stanford University | 2012-10-01 |
| Safety Study of Human Anti-Cytomegalovirus Monoclonal Antibody (NCT01594437) | Theraclone Sciences, Inc. | 2012-05-01 |
| Using Multi-virus Cytotoxic T-cells Following T-Cell Depleted Allogeneic HPCT for Prophylaxis Against EBV, ADV, and CMV (NCT01535885) | Medical College of Wisconsin | 2012-02-01 |
| A Study on Spermatogenesis in Male Renal Transplant Recipients Receiving Valganciclovir (Valcyte®) Versus Untreated Matched Controls (NCT01663740) | Hoffmann-La Roche | 2012-01-30 |
| Trial of CMV Specific DLIs From 3-6/6 HLA Matched Family Member Following Nonmyeloablative Allo SCT (NCT01274377) | Nelson Chao | 2011-02-01 |
| Administration of Rapidly Generated Multivirus-specific Cytotoxic T-Lymphocytes (VIRAGE) (NCT01070797) | Baylor College of Medicine | 2011-01-01 |
| Study of the Transmission of Cytomegalovirus (CMV) Infection From Mother to Foetus (NCT01251744) | GlaxoSmithKline | 2010-12-09 |
| Injection of CD4 and CD8 + T Cells Anti-Cytomegalovirus (CMV) or Anti-adenovirus (NCT01325636) | Assistance Publique - Hôpitaux de Paris | 2010-09-01 |
| An Observational Study of Valcyte (Valganciclovir) in D+/R- Liver Transplant Recipients (NCT02062294) | Hoffmann-La Roche | 2010-07-31 |
| Comparison of Two Immunosuppressive Regimens in Kidney Transplant Recipients With Deceased Donors With the Aim of Preventing the Development of Fibrosis / Atrophy of Reducing the Incidence of Cytomegalovirus Infection (NCT01353053) | Federal University of São Paulo | 2010-07-01 |
| Cytomegalovirus Infection in Patients With HIV-1 Infection (NCT04067869) | University Hospital, Bordeaux | 2010-02-16 |
| Evaluation of the Artus® CMV PCR Test (NCT01034709) | QIAGEN Gaithersburg, Inc | 2009-12-01 |
| Cytomegalovirus (CMV) Specific Cytotoxic T Lymphocytes (CTL) When Used for Prophylaxis Against CMV in Recipients of Allogeneic, T Cell Depleted Stem Cell Transplants (NCT00673868) | Milton S. Hershey Medical Center | 2007-10-01 |
| Trial of Donor T Cells Sensitized With Pentadecapeptides of the CMV-PP65 Protein for the Treatment of Cytomegalovirus (CMV) Infections Following Allogeneic Hematopoietic Stem Cell Transplants (NCT00674648) | Memorial Sloan Kettering Cancer Center | 2007-08-01 |
| Maribavir Versus Oral Ganciclovir For The Prevention of Cytomegalovirus (CMV) Disease in Liver Transplant Recipients (NCT00497796) | Shire | 2007-07-23 |
| Evaluation of the Safety and Immune Responses of the Towne Strain of CMV in Seronegative Women (NCT00201448) | Virginia Commonwealth University | 2007-06-01 |
| A Clinical Trial of an Alphavirus Replicon Vaccine for Cytomegalovirus (CMV) (NCT00439803) | AlphaVax, Inc. | 2007-04-01 |
| Prophylactic Use of Maribavir for the Prevention of Cytomegalovirus (CMV) Disease in Stem Cell Transplant Recipients (NCT00411645) | Shire | 2006-12-13 |
| CMV Glycoprotein B Vaccine in Allograft Recipients (NCT00299260) | University College, London | 2006-08-01 |
| Valganciclovir to Reduce T Cell Activation in HIV Infection (NCT00264290) | University of California, San Francisco | 2006-08-01 |
| Artesunate in Preemptive Treatment of Human Cytomegalovirus (CMV) in Stem Cell Transplant Recipients (NCT00284687) | Hadassah Medical Organization | 2006-07-01 |
| gB/MF59 Vaccine in Preventing Cytomegalovirus Infection in Healthy Adolescent Females (NCT00133497) | National Institute of Allergy and Infectious Diseases (NIAID) | 2006-06-01 |
| CMV Infection in Adolescent Males (NCT00302029) | National Institute of Allergy and Infectious Diseases (NIAID) | 2006-06-01 |
| Cytomegalovirus Cell-Mediated Immunity (NCT00815165) | National Institute of Allergy and Infectious Diseases (NIAID) | 2006-06-01 |
| A Study of Valcyte (Valganciclovir) CMV Prophylaxis After Renal Transplantation (NCT00372229) | Hoffmann-La Roche | 2006-05-01 |
| IMPACT Study: A Study of Valcyte (Valganciclovir) for Prevention of Cytomegalovirus Disease (CMV) in Kidney Allograft Recipients (NCT00294515) | Hoffmann-La Roche | 2006-03-31 |
| Ganciclovir Pharmacokinetics in Patients Undergoing Continuous Renal Replacement Therapy (NCT00264368) | University of Oslo School of Pharmacy | 2005-12-01 |
| Genotyping of Cytomegalovirus From Patients in Israel (NCT00228202) | Sheba Medical Center | 2005-09-01 |
| A Relative Bioavailability Study of Valcyte (Valganciclovir) in Lung Transplant Recipients With or Without Cystic Fibrosis. (NCT00377741) | Hoffmann-La Roche | 2004-12-01 |
| Risk Factors for Cytomegalovirus Disease in Solid Organ Transplantation (NCT00170170) | Mayo Clinic | 2004-11-01 |
| Trial of Preemptive Treatment With Oral Valganciclovir Compared With Intravenous (IV) Ganciclovir for Cytomegalovirus Infection After Bone Marrow or Peripheral Blood Stem Cell Transplant (NCT00241345) | Washington University School of Medicine | 2004-06-01 |
| Accelerated Immunization to Induce Cytomegalovirus Immunity in Stem Cell Donors (NCT00353977) | National Heart, Lung, and Blood Institute (NHLBI) | 2004-05-01 |
| A Study of Valcyte (Valganciclovir) Syrup Formulation in Pediatric Solid Organ Transplant Recipients (NCT00090766) | Hoffmann-La Roche | 2004-05-01 |
| VICTOR Study - A Study of Valcyte (Valganciclovir po) Compared to Ganciclovir iv in Patients With Cytomegalovirus (CMV) Disease Who Are Solid Organ Transplant Recipients (NCT00431353) | Hoffmann-La Roche | 2004-04-01 |
| Cytotoxic T-Lymphocytes for the Prophylaxis of Cytomegalovirus After Allogeneic Stem Cell Transplant (NCT00078533) | Baylor College of Medicine | 2004-04-01 |
| MICI-CMV:Valganciclovir in Recurrent Bouts of Cryptogenic Inflammatory Bowel Diseases With an Infection by Cytomegalovirus (NCT00237653) | University Hospital, Grenoble | 2004-02-01 |
| Comparison of Oral Valganciclovir and Placebo for the Prevention of Cytomegalovirus (CMV) After Lung Transplantation (NCT00227370) | Duke University | 2003-07-01 |
| Immune Response to Cytomegalovirus (NCT00034437) | National Heart, Lung, and Blood Institute (NHLBI) | 2002-04-01 |
| Neonatal CMV-Ganciclovir Follow-up Study (NCT00031421) | National Institute of Allergy and Infectious Diseases (NIAID) | 2001-09-01 |
| The Influence of Intensive Education and Coaching on Compliance for Oral Ganciclovir in the Prophylaxis of CMV: an Open Randomised Trial (NCT00566072) | University Hospital, Ghent | 2001-05-01 |
| Transfusion Infections Pediatric Prospective Study (TRIPPS) (NCT00029406) | Naomi Luban | 2001-04-01 |